Teladoc Health, Inc. (NYSE:TDOC - Get Free Report)'s share price traded up 9% during mid-day trading on Friday . The company traded as high as $14.39 and last traded at $14.73. 6,387,505 shares were traded during trading, an increase of 7% from the average session volume of 5,963,633 shares. The stock had previously closed at $13.51.
Analyst Ratings Changes
Several equities analysts have commented on TDOC shares. Deutsche Bank Aktiengesellschaft boosted their price target on shares of Teladoc Health from $10.00 to $12.00 and gave the stock a "hold" rating in a research note on Friday, November 1st. The Goldman Sachs Group upped their price target on Teladoc Health from $14.00 to $16.00 and gave the stock a "buy" rating in a report on Tuesday. Barclays lifted their price objective on Teladoc Health from $10.00 to $12.00 and gave the company an "overweight" rating in a research note on Thursday, October 31st. Oppenheimer lowered their price objective on Teladoc Health from $14.00 to $12.00 and set an "outperform" rating for the company in a research report on Friday, January 24th. Finally, Piper Sandler reaffirmed an "overweight" rating and issued a $13.00 target price (up previously from $11.00) on shares of Teladoc Health in a report on Wednesday, December 4th. Fourteen analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $12.18.
Get Our Latest Stock Analysis on Teladoc Health
Teladoc Health Stock Down 8.5 %
The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. The business has a 50 day moving average of $10.41 and a 200-day moving average of $9.35. The stock has a market cap of $2.26 billion, a PE ratio of -2.27 and a beta of 1.05.
Insider Activity at Teladoc Health
In related news, insider Carlos Nueno sold 2,389 shares of the firm's stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $11.93, for a total transaction of $28,500.77. Following the transaction, the insider now owns 2,890 shares of the company's stock, valued at $34,477.70. This trade represents a 45.25 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. 0.95% of the stock is owned by insiders.
Institutional Trading of Teladoc Health
A number of hedge funds have recently added to or reduced their stakes in the stock. Point72 Asset Management L.P. raised its stake in shares of Teladoc Health by 57.8% during the third quarter. Point72 Asset Management L.P. now owns 8,366,295 shares of the health services provider's stock worth $76,803,000 after purchasing an additional 3,063,172 shares during the last quarter. Maple Rock Capital Partners Inc. raised its position in Teladoc Health by 189.5% during the 4th quarter. Maple Rock Capital Partners Inc. now owns 3,561,000 shares of the health services provider's stock worth $32,369,000 after buying an additional 2,331,000 shares during the last quarter. Two Sigma Investments LP acquired a new stake in shares of Teladoc Health in the 4th quarter worth $18,348,000. Assenagon Asset Management S.A. acquired a new stake in shares of Teladoc Health in the 3rd quarter worth $15,801,000. Finally, Two Sigma Advisers LP boosted its holdings in shares of Teladoc Health by 213.0% in the fourth quarter. Two Sigma Advisers LP now owns 2,258,711 shares of the health services provider's stock valued at $20,532,000 after acquiring an additional 1,537,094 shares in the last quarter. 76.82% of the stock is owned by institutional investors and hedge funds.
Teladoc Health Company Profile
(
Get Free Report)
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Further Reading
Before you consider Teladoc Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.
While Teladoc Health currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
